Please assess the completion status of the following clinical trial:

Trial Title: Nab-Paclitaxel in Combination With Carboplatin as First-line Therapy in Patients With NSCLC

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Histologically confirmed diagnosis of locally advanced / metastatic, unresectable NSCLC~* According to SmPC~Exclusion Criteria:~* According to SmPC

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 99 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).